Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-19-002297

Director acquired 3,757,430 shares (other)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS, L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2019-03-08 Other acquisition : show line 1 in the form +3,757,430 33,728,991 D
2019-03-08 Other acquisition : show line 2 in the form +0 33,728,991 I
Loading xslF345X03/ownership.xml…